Axsome Therapeutics (AXSM) PT Raised to 'Street High' $158 at Guggenheim
Tweet Send to a Friend
Guggenheim analyst Yatin Suneja raised the price target on Axsome Therapeutics (NASDAQ: AXSM) to $158.00 (from $65.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
